Fulvestrant Versus Capecitabine as Maintenance Therapy After First-line Chemotherapy in Patients With HR+/HER2- Metastatic Breast Cancer
Clinical trial NCT04263298 · RECRUITING
Trial details
- NCT number
- NCT04263298
- Sponsor
- Herui Yao
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-01
- Primary completion
- 2025-05-01
- Enrollment
- 210
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.